Qu Jian, Ouyang Zhanbo, Wu Wenqiang, Li Guohua, Wang Jiaojiao, Lu Qiong, Li Zhihong
Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China.
Hunan Key Laboratory of Tumor Models and Individualized Medicine, The Second Xiangya Hospital, Central South University, Changsha, China.
Front Cell Dev Biol. 2020 Jun 30;8:534. doi: 10.3389/fcell.2020.00534. eCollection 2020.
Super-enhancers (SEs) are a large cluster of -regulatory DNA elements that contain many binding motifs, which master transcription factors and cofactors bind to with high density. SEs usually regulate the expression of genes that can control the cell identity and fate, and SEs can be used to explain the patterns of the expression of cell-specific genes. Hence, it shows great potential for application in the treatment of diseases like cancer. At present, the clinical treatments for osteosarcoma, Ewing sarcoma, and other bone-related diseases remain challenging. The poor prognosis and difficult treatment of these diseases imposes heavy economic burden on patients and society. In recent years, research on SEs with respect to bone-related diseases has attracted increasing attention. In this paper, we first review the identification and functional mechanisms of SEs. Then, we integrate the findings of the emerging studies on SEs in bone-related diseases. Finally, we summarize recent strategies for targeting SEs for the treatment of bone-related diseases. This review aims to provide comprehensive insights into the roles of SEs in bone-related diseases.
超级增强子(SEs)是一大簇调控性DNA元件,包含许多结合基序,主转录因子和辅因子会高密度地与其结合。SEs通常调控那些能够控制细胞特性和命运的基因的表达,并且SEs可用于解释细胞特异性基因的表达模式。因此,它在癌症等疾病的治疗中显示出巨大的应用潜力。目前,骨肉瘤、尤因肉瘤和其他骨相关疾病的临床治疗仍然具有挑战性。这些疾病预后差且治疗困难,给患者和社会带来了沉重的经济负担。近年来,关于SEs在骨相关疾病方面的研究越来越受到关注。在本文中,我们首先综述SEs的鉴定和功能机制。然后,我们整合了关于SEs在骨相关疾病方面新兴研究的结果。最后,我们总结了针对SEs治疗骨相关疾病的最新策略。本综述旨在全面深入了解SEs在骨相关疾病中的作用。